Found: 5
Select item for more details and to access through your institution.
Kinome inhibition states and multiomics data enable prediction of cell viability in diverse cancer types.
- Published in:
- PLoS Computational Biology, 2023, v. 19, n. 2, p. 1, doi. 10.1371/journal.pcbi.1010888
- By:
- Publication type:
- Article
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1481, doi. 10.1093/neuonc/nox052
- By:
- Publication type:
- Article
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1191217
- By:
- Publication type:
- Article
Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17797
- By:
- Publication type:
- Article
Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16342
- By:
- Publication type:
- Article